We are live on
!
Find out more
FC
Fairpointe Capital Portfolio holdings
AUM
$66.3M
1-Year Est. Return
101.32%
This Fund
S&P 500
This Quarter
Est. Return
+6.34%
1 Year Est. Return
+101.32%
3 Year Est. Return
+48.06%
5 Year Est. Return
+95.29%
10 Year Est. Return
–
AUM
$4.98B
AUM Growth
–
Cap. Flow
+$4.84B
Cap. Flow
% of AUM
97.17%
Top 10 Holdings %
Top 10 Hldgs %
34.98%
Holding
72
New
72
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$211M |
| 2 |
HSP
HOSPIRA INC
HSP
|
+$190M |
| 3 |
CVSA
Covista Inc
CVSA
|
+$184M |
| 4 |
SPLS
Staples Inc
SPLS
|
+$175M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$159M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.83% |
| 2 | Industrials | 13.24% |
| 3 | Healthcare | 13.15% |
| 4 | Communication Services | 11.17% |
| 5 | Consumer Discretionary | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNSR
51
DELISTED
Finisar Corp
FNSR
| $2.52M | 0.05% |
+148,700
| New | +$2.02M |
|
|
CBI
52
DELISTED
Chicago Bridge & Iron Nv
CBI
| $2.37M | 0.05% |
+39,680
| New | +$2.31M |
|
53
Sensient Technologies
SXT
$5.22B
| $1.32M | 0.03% |
+32,700
| New | +$1.3M |
|
54
HP
HPQ
$26B
| $1.01M | 0.02% |
+90,062
| New | +$919K |
|
|
TW
55
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $934K | 0.02% |
+11,400
| New | +$858K |
|
|
LM
56
DELISTED
Legg Mason, Inc.
LM
| $856K | 0.02% |
+27,600
| New | +$902K |
|
|
WOOF
57
DELISTED
VCA Inc.
WOOF
| $741K | 0.01% |
+28,400
| New | +$688K |
|
58
APA Corp
APA
$13B
| $668K | 0.01% |
+7,970
| New | +$633K |
|
59
Carnival Corporation Ltd
CCL
$38.1B
| $650K | 0.01% |
+18,950
| New | +$642K |
|
60
Cenovus Energy
CVE
$54.2B
| $645K | 0.01% |
+22,600
| New | +$668K |
|
|
AVP
61
DELISTED
Avon Products, Inc.
AVP
| $612K | 0.01% |
+29,100
| New | +$653K |
|
62
PepsiCo
PEP
$196B
| $573K | 0.01% |
+7,000
| New | +$572K |
|
|
QVCGA
63
DELISTED
QVC Group Inc Series A
QVCGA
| $557K | 0.01% |
+589
| New | +$532K |
|
64
Unilever
UL
$142B
| $546K | 0.01% |
+12,000
| New | +$570K |
|
65
IBM
IBM
$213B
| $314K | 0.01% |
+1,716
| New | +$334K |
|
66
JPMorgan Chase
JPM
$916B
| $311K | 0.01% |
+5,899
| New | +$300K |
|
67
Novartis
NVS
$302B
| $251K | 0.01% |
+3,962
| New | +$258K |
|
|
DISCK
68
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $238K | ﹤0.01% |
+6,820
| New | +$238K |
|
69
Telus
TU
$17.4B
| $219K | ﹤0.01% |
+15,000
| New | +$260K |
|
Similar funds
EFM
NI
UL
WSC
AGEC
CIA
FLSMF
OHS
Fairpointe Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Fairpointe Capital, which disclosed 72 positions worth $4.98B. Its ten largest holdings account for 35% of the portfolio.
Its largest position is Boston Scientific: 24,892,805 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, followed by Industrials and Healthcare.
- Fairpointe Capital's largest Q2 2013 buy was Boston Scientific: 24,892,805 shares worth $231M.
- Fairpointe Capital's ten largest holdings make up 35% of its $4.98B portfolio in Q2 2013.
- Fairpointe Capital disclosed 72 positions in Q2 2013, its first 13F filing on record.
Based on Fairpointe Capital's 13F filing for Q2 2013, filed 7 Aug 2013.